Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
Bénédicte ClarisseNicolas GoardonJustine LequesneDominique VaurRenaud CiappucciniAlexandra LeconteHervé MonpeyssenVirginie Saguet-RysanekBénédicte ClarisseAudrey Lasne-CardonFabrice MénégauxLaurence LeenhardtCamille BuffetPublished in: Endocrine (2020)
By increasing the overall risk of cancer from 16 to 67% in mutated nodules and by diminishing it to 9% in wild-type, this study confirms the relevance of the 7-panel mutation testing in the diagnostic of nodules with IC. Genetic testing, however, did not predict outcome in the cancer patient subgroup.